Erik Schadde

4.8k total citations · 1 hit paper
69 papers, 2.3k citations indexed

About

Erik Schadde is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Erik Schadde has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hepatology, 43 papers in Surgery and 25 papers in Oncology. Recurrent topics in Erik Schadde's work include Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Organ Transplantation Techniques and Outcomes (21 papers) and Liver Disease Diagnosis and Treatment (17 papers). Erik Schadde is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Organ Transplantation Techniques and Outcomes (21 papers) and Liver Disease Diagnosis and Treatment (17 papers). Erik Schadde collaborates with scholars based in Switzerland, United States and Germany. Erik Schadde's co-authors include Pierre–Alain Clavien, Eduardo de Santibáñes, Andreas A. Schnitzbauer, Roberto Hernandez‐Alejandro, Christoph Tschuor, Victoria Ardiles, Ksenija Slankamenac, Marcel Autran C. Machado, Dimitri Aristotle Raptis and Massimo Malagò and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Erik Schadde

66 papers receiving 2.3k citations

Hit Papers

Early Survival and Safety of ALPPS 2014 2026 2018 2022 2014 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Survival and Safety of ALPPS
    2014 295 citations Erik Schadde, Victoria Ardiles et al. Annals of Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Schadde Switzerland 24 1.9k 1.5k 780 683 341 69 2.3k
Jaume Torras Spain 22 1.2k 0.6× 1.1k 0.7× 491 0.6× 475 0.7× 350 1.0× 88 1.9k
Gaetano Vetrone Italy 19 957 0.5× 929 0.6× 491 0.6× 322 0.5× 336 1.0× 37 1.5k
Juan Fabregat Spain 16 835 0.4× 926 0.6× 411 0.5× 506 0.7× 300 0.9× 60 1.4k
Juan R. Madariaga United States 27 1.3k 0.7× 1.9k 1.2× 403 0.5× 742 1.1× 663 1.9× 44 2.6k
Maria B. Majella Doyle United States 17 855 0.4× 786 0.5× 374 0.5× 285 0.4× 263 0.8× 61 1.3k
Muhammad F. Dawwas United Kingdom 14 674 0.4× 685 0.4× 543 0.7× 311 0.5× 279 0.8× 22 1.2k
Valério Lucidi Belgium 17 790 0.4× 569 0.4× 368 0.5× 316 0.5× 153 0.4× 66 1.2k
Claude Tayar France 20 1.8k 0.9× 1.4k 0.9× 559 0.7× 1000 1.5× 574 1.7× 47 2.3k
Juli Busquets Spain 20 607 0.3× 980 0.6× 323 0.4× 520 0.8× 273 0.8× 99 1.4k
Steven I. Hanish United States 20 627 0.3× 581 0.4× 368 0.5× 193 0.3× 395 1.2× 56 1.4k

Countries citing papers authored by Erik Schadde

Since Specialization
Citations

This map shows the geographic impact of Erik Schadde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Schadde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Schadde more than expected).

Fields of papers citing papers by Erik Schadde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Schadde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Schadde. The network helps show where Erik Schadde may publish in the future.

Co-authorship network of co-authors of Erik Schadde

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Schadde. A scholar is included among the top collaborators of Erik Schadde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Schadde. Erik Schadde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kent, Paul, Abhinav Humar, Oliver M. Fisher, et al.. (2024). Lenvatinib, gemcitabine, and oxaliplatin for 67 patients with fibrolamellar carcinoma.. Journal of Clinical Oncology. 42(16_suppl). e16151–e16151.
2.
Beck‐Schimmer, Beatrice, Erik Schadde, Urs Pietsch, et al.. (2024). Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial. Annals of Intensive Care. 14(1). 41–41. 3 indexed citations
3.
Olthof, Pim B., Jan Heil, Geert Kazemier, et al.. (2024). Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein Embolization. CardioVascular and Interventional Radiology. 47(5). 642–649. 1 indexed citations
4.
Kent, Paul, Erik Schadde, Oliver M. Fisher, et al.. (2023). First report of tumor-informed circulating tumor DNA in fibrolamellar carcinoma in adolescents and young adults: 51 patients.. Journal of Clinical Oncology. 41(16_suppl). 3034–3034.
5.
6.
Smits, J.M.M., Maxime Dewulf, Rafael Díaz-Nieto, et al.. (2023). DRAGON 2 - Protocol - An International Multicentre Randomized Controlled Trial Comparing Combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE Alone. HPB. 25. S289–S289. 9 indexed citations
7.
Santos, Carlos A.Q., Yoona Rhee, Edward F. Hollinger, et al.. (2021). Comparative incidence and outcomes of COVID‐19 in kidney or kidney‐pancreas transplant recipients versus kidney or kidney‐pancreas waitlisted patients: A single‐center study. Clinical Transplantation. 35(8). e14362–e14362. 4 indexed citations
8.
Schadde, Erik, Boris Guiu, Rebecca Deal, et al.. (2018). Simultaneous hepatic and portal vein ligation induces rapid liver hypertrophy: A study in pigs. Surgery. 165(3). 525–533. 25 indexed citations
9.
10.
Keutgen, Xavier M., Erik Schadde, Rodney F. Pommier, et al.. (2018). Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver. Seminars in Oncology. 45(4). 232–235. 22 indexed citations
11.
Enne, Marcelo, Erik Schadde, Bergþór Björnsson, et al.. (2017). ALPPS as a salvage procedure after insufficient future liver remnant hypertrophy following portal vein occlusion. HPB. 19(12). 1126–1129. 27 indexed citations
12.
Schadde, Erik, Massimo Malagò, Roberto Hernandez‐Alejandro, et al.. (2016). ALPPS monosegment resections allow a further extension of the limitations of resectability in colorectal liver metastases. HPB. 18. e702–e702. 1 indexed citations
13.
14.
Schadde, Erik, Marzena Swiderska‐Syn, Stefan Breitenstein, et al.. (2016). Hypoxia of the growing liver accelerates regeneration. Surgery. 161(3). 666–679. 51 indexed citations
15.
Schadde, Erik, Dimitri Aristotle Raptis, Andreas A. Schnitzbauer, et al.. (2015). Prediction of Mortality After ALPPS Stage-1. Annals of Surgery. 262(5). 780–786. 157 indexed citations
16.
Schadde, Erik, Andreas A. Schnitzbauer, Christoph Tschuor, et al.. (2014). Systematic Review and Meta-Analysis of Feasibility, Safety, and Efficacy of a Novel Procedure: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Annals of Surgical Oncology. 22(9). 3109–3120. 99 indexed citations
17.
Schadde, Erik, Victoria Ardiles, R Robles, et al.. (2014). Early Survival and Safety of ALPPS. Annals of Surgery. 260(5). 829–838. 295 indexed citations breakdown →
18.
Glenck, Michael, et al.. (2013). Stent-Graft Repairs of Visceral and Renal Artery Aneurysms Are Effective and Result in Long-term Patency. Journal of Vascular and Interventional Radiology. 24(7). 989–996. 41 indexed citations
19.
Schadde, Erik, Ksenija Slankamenac, Stefan Breitenstein, et al.. (2012). Are two‐stage hepatectomies associated with more complications than one‐stage procedures?. HPB. 15(6). 411–417. 12 indexed citations
20.
Kwun, Jean, Selçuk Hazinedaroğlu, Erik Schadde, et al.. (2008). Unaltered Graft Survival and Intragraft Lymphocytes Infiltration in the Cardiac Allograft of Cxcr3−/− Mouse Recipients. American Journal of Transplantation. 8(8). 1593–1603. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaume Torras Breakdown of academic impact, for papers by Gaetano Vetrone Breakdown of academic impact, for papers by Juan Fabregat Breakdown of academic impact, for papers by Juan R. Madariaga Breakdown of academic impact, for papers by Maria B. Majella Doyle Breakdown of academic impact, for papers by Muhammad F. Dawwas Breakdown of academic impact, for papers by Valério Lucidi Breakdown of academic impact, for papers by Claude Tayar Breakdown of academic impact, for papers by Juli Busquets Breakdown of academic impact, for papers by Steven I. Hanish
Rankless by CCL
2026